Skip to content
September 18, 2025

ChenPak Investment

  • English
    • 中文
    • English
  • About Us
  • All Company
  • Contact Us
Newsletter
Random News
  • Home
  • DXN

Tag: DXN

  • Target Price Research
2 months ago

DXN Holdings (DXN MK): Growth Masked By Unfavourable FX; Still BUY

DXN Holdings: Growth Masked By Unfavourable FX; Still BUY RHB 30 July 2025 DXN Holdings (DXN MK): Growth Masked By Unfavourable FX; Still BUY Consumer Cyclical | Consumer Products Shariah Compliant BUY (Maintained) Target Price (Return): MYR0.80 (+58%) Price (Market Cap): MYR0.51 (USD593m) ESG score: 2.9 (out of 4) Avg Daily Turnover (MYR/USD): 1.13m/0.26m Analyst…

Read More
chenpak018 mins
  • Quarter Report Analysis
2 months ago1 month ago

DXN Holdings Bhd. Q1 2025 Latest Quarterly Report Analysis

“`html DXN Q1 FY2026 Analysis DXN’s Q1 FY2026 Report: Steady Revenue Amidst Forex Headwinds and a Dividend Declaration Global health and wellness giant, DXN Holdings Bhd., has just released its financial results for the first quarter ended May 31, 2025. The report reveals a story of operational resilience with steady revenue growth, even as profitability…

Read More
chenpak09 mins
  • Quarter Report Analysis
2 months ago1 month ago

DXN Holdings Bhd. Q1 2025 Latest Quarterly Report Analysis

“`html DXN’s Q1 2026 Report: Navigating Forex Headwinds with Steady Revenue and an Eye on Global Expansion Published on: July 30, 2025 DXN Holdings Bhd., a major player in the global health and wellness direct-selling market, has just released its latest quarterly results. The report for the first quarter ended May 31, 2025 (Q1 FY2026),…

Read More
chenpak08 mins

Recent Posts

  • 马来西亚股票分析报告
  • 马来西亚股票分析报告
  • KEPONG: Integrated TechPark Initiative Poised to Boost Future Earnings
  • 马来西亚股票分析报告
  • UMC: Medical Device Manufacturer Eyes Stronger Margins and Expanded Markets

Recent Comments

No comments to show.

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025

Categories

  • Quarter Report Analysis
  • Target Price Research
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Contact Us
  • Sitemap
  • General Disclaimer